Eduardo Lorca
Overview
Explore the profile of Eduardo Lorca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez A, Cazzolli R, Madero M, Evangelidis N, Howell M, Sautenet B, et al.
Am J Kidney Dis
. 2025 Jan;
PMID: 39855535
Omitting outcomes of importance to patients with chronic kidney disease (CKD) and their caregivers from trials can impede decision-making based on patient-centered outcomes. As part of the global Standardized Outcomes...
2.
Cabrera S, Walbaum M, Lorca E, Borquez T, Mezzano S, Tagle R, et al.
Rev Med Chil
. 2024 Oct;
152(2):244-252.
PMID: 39450801
The Chilean consensus on the use of SGLT-2 inhibitors (iSGLT-2) in clinical practice, jointly developed by the societies of Cardiology, Diabetes, Family Medicine, and Nephrology, strongly recommends the use of...
3.
Gonzalez A, Evangelidis N, Howell M, Jaure A, Sautenet B, Madero M, et al.
Nephrol Dial Transplant
. 2024 Jan;
39(8):1310-1321.
PMID: 38236705
Background: Many outcomes of high priority to patients and clinicians are infrequently and inconsistently reported across trials in chronic kidney disease (CKD), which generates research waste and limits evidence-informed decision...
4.
Pedreros-Rosales C, Jara A, Lorca E, Mezzano S, Pecoits-Filho R, Herrera P
Toxins (Basel)
. 2023 Sep;
15(9).
PMID: 37755957
Dialysis treatment has improved the survival of patients with kidney failure. However, the hospitalization and mortality rates remain alarmingly high, primarily due to incomplete uremic toxin elimination. High-volume hemodiafiltration (HDF)...
5.
Gonzalez A, Lorca E, Cabrera S, Hernandez A, Zuniga-Sm C, Sola L, et al.
BMJ Open
. 2023 May;
13(5):e062321.
PMID: 37173110
Objective: To describe the experiences of nephrologists on caring for patients undergoing in-centre haemodialysis during the COVID-19 pandemic in Latin America. Design: Twenty-five semistructured interviews were conducted by Zoom videoconference...
6.
Michea L, Toro L, Alban N, Contreras D, Morgado P, Paccot M, et al.
Rev Panam Salud Publica
. 2022 Sep;
46:e138.
PMID: 36082021
Objective: To evaluate the effectiveness of a standardized and simplified protocol based on the technical pillars of the HEARTS Initiative for the control of hypertensive patients in the Cardiovascular Health...
7.
Torres R, Toro L, Sanhueza M, Lorca E, Ortiz M, Pefaur J, et al.
Kidney Int Rep
. 2022 Jul;
7(10):2176-2185.
PMID: 35874643
Introduction: The COVID-19 pandemic is a global public health problem. Patients with end-stage renal disease on hemodialysis are at a higher risk of infection and mortality than the general population....
8.
Ortiz A, Sepulveda R, Torres R, Clavero R, Toro L, Albornoz M, et al.
Perit Dial Int
. 2022 Mar;
42(5):535-539.
PMID: 35352596
The Covid-19 pandemic has been responsible for millions of deaths worldwide. Patients with comorbidities- such as those on peritoneal dialysis (PD)- present higher morbidity and mortality than the general population....
9.
Gardiner E, Baumgart A, Tong A, Elliott J, Azevedo L, Bersten A, et al.
J Ment Health
. 2022 Jan;
31(4):524-533.
PMID: 34983279
Background: The coronavirus (COVID-19) pandemic has seen a global surge in anxiety, depression, post-traumatic stress disorder (PTSD), and stress. Aims: This study aimed to describe the perspectives of patients with...
10.
Pefaur J, Toro L, Lorca E, Torres R
Transplantation
. 2021 Nov;
106(4):680-684.
PMID: 34759256
No abstract available.